Description

Zuvotolimod is a myeloid cell agonist compound-linker for antibody conjugate. Zuvotolimod can be used in the research of cancer and hepatitis[1][2].–20°C (Powder, sealed storage, away from moisture and light)-Applications-COVID-19-immunoregulation-Formula-C55H70N12O10-Citation–References-[1]Peter Armstrong Thompson, et al. Anti-liver cell or viral antigen antibody conjugate with myeloid cell agonist for treatment of hepatitis. Patent WO2019118884 A1.|[2] Sean Wesley Smith, et al. Preparation of benzazepines and their conjugates containing peptidyl linkers for the treatment of cancer and modulation of TLR8. Patent WO2020056194 A1.-CASNumber-2355262-97-2-MolecularWeight-1059.22-Compound Purity-99.46-SMILES-O=C(N1CC(C=C(NC(C2=CC3=C(C=C(C(N(CCC)CCC)=O)CC(N)=N3)C=C2)=O)C=N4)=C4CC1)OCC5=CC=C(NC([C@](NC([C@@](C(C)C)([H])NC(CCCCCN6C(C=CC6=O)=O)=O)=O)([H])CCCNC(N)=O)=O)C=C5-Research_Area-Cancer; Inflammation/Immunology-Solubility-10 mM in DMSO-Target-ADC Linker-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related